Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.

Devic's neuromyelitis optica is an inflammatory demyelinating disorder normally restricted to the optic nerves and spinal cord. Since the identification of a specific autoantibody directed against aquaporin 4, neuromyelitis optica-immunoglobulin G/aquaporin 4 antibody, neuromyelitis optica has been considered an entity distinct from multiple sclerosis. Recent findings indicate that the neuromyelitis optica-immunoglobulin G/aquaporin 4 antibody has a pathogenic role through complement-dependent astrocyte toxicity. However, the link with demyelination remains elusive. Autoantibodies can act as receptor agonists/antagonists or alter antigen density in their target cells. We hypothesized that the neuromyelitis optica-immunoglobulin G/aquaporin 4 antibody impairs astrocytic function and secondarily leads to demyelination. Rat astrocytes and oligodendrocytes from primary cultures and rat optic nerves were exposed long-term (24 h) to immunoglobulin G in the absence of complement. Immunoglobulin G was purified from the serum of patients with neuromyelitis optica who were either neuromyelitis optica-immunoglobulin G/aquaporin 4 antibody positive or negative, as well as from healthy controls. Flow cytometry analysis showed a reduction of membrane aquaporin 4 and glutamate transporter type 1 on astrocytes following contact with immunoglobulin G purified from neuromyelitis optica-immunoglobulin G/aquaporin 4 antibody positive serum only. The activity of glutamine synthetase, an astrocyte enzyme converting glutamate into glutamine, decreased in parallel, indicating astrocyte dysfunction. Treatment also reduced oligodendrocytic cell processes and approximately 30% oligodendrocytes died. This deleterious effect was confirmed ex vivo; exposed optic nerves showed reduction of myelin basic protein. Immunoglobulin G from neuromyelitis optica-immunoglobulin G/aquaporin 4 antibody seronegative patients and from healthy controls had no similar effect. Neuromyelitis optica-immunoglobulin G/aquaporin 4 antibody did not directly injure oligodendrocytes cultured without astrocytes. A toxic bystander effect of astrocytes damaged by neuromyelitis optica-immunoglobulin G/aquaporin 4 antibody on oligodendrocytes was identified. Progressive accumulation of glutamate in the culture medium of neuromyelitis optica-immunoglobulin G/aquaporin 4-antibody-treated glial cells supported the hypothesis of a glutamate-mediated excitotoxic death of oligodendrocytes in our models. Moreover, co-treatment of glial cultures with neuromyelitis optica-immunoglobulin G/aquaporin 4 antibody and d+2-amino-5-phosphonopentanoic acid, a competitive antagonist at the N-methyl-d-aspartate/glutamate receptor, partially protected oligodendrocytes. Co-immunolabelling of oligodendrocyte markers and neuromyelitis optica-immunoglobulin G/aquaporin 4 antibody showed that astrocytic positive processes were in close contact with oligodendrocytes and myelin in rat optic nerves and spinal cord, but far less so in other parts of the central nervous system. This suggests a bystander effect of neuromyelitis optica-immunoglobulin G-damaged astrocytes on oligodendrocytes in the nervous tissues affected by neuromyelitis optica. In conclusion, in these cell culture models we found a direct, complement-independent effect of neuromyelitis optica-immunoglobulin G/aquaporin 4 antibody on astrocytes, with secondary damage to oligodendrocytes possibly resulting from glutamate-mediated excitotoxicity. These mechanisms could add to the complement-induced damage, particularly the demyelination, seen in vivo.

[1]  M. Verbeek,et al.  Glial but not axonal protein biomarkers as a new supportive diagnostic criteria for Devic neuromyelitis optica? Preliminary results on 188 patients with different neurological diseases , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[2]  Robert Zorec,et al.  Gliotransmission: Exocytotic release from astrocytes , 2010, Brain Research Reviews.

[3]  M. Papadopoulos,et al.  Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. , 2010, Brain : a journal of neurology.

[4]  Y. Itoyama,et al.  Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo , 2009, Annals of neurology.

[5]  Y. Blanco,et al.  Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: An in vitro study , 2009, Journal of Neuroimmunology.

[6]  V. Parpura,et al.  Dual regulation of Ca2+‐dependent glutamate release from astrocytes: Vesicular glutamate transporters and cytosolic glutamate levels , 2009, Glia.

[7]  B. Volpe,et al.  Losing your nerves? Maybe it's the antibodies , 2009, Nature Reviews Immunology.

[8]  Y. Itoyama,et al.  Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

[9]  K. Fujihara,et al.  Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum , 2009, Neuroreport.

[10]  C. Lucchinetti,et al.  Aquaporin-4–binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2 , 2008, The Journal of experimental medicine.

[11]  A. Bar-Or,et al.  Functional Consequences of Neuromyelitis Optica-IgG Astrocyte Interactions on Blood-Brain Barrier Permeability and Granulocyte Recruitment1 , 2008, The Journal of Immunology.

[12]  Amaia M. Arranz,et al.  Functional glutamate transport in rodent optic nerve axons and glia , 2008, Glia.

[13]  D. McAdoo,et al.  Glutamate-induced losses of oligodendrocytes and neurons and activation of caspase-3 in the rat spinal cord , 2008, Neuroscience.

[14]  H. Weiner,et al.  Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. , 2008, The Journal of clinical investigation.

[15]  P. Vermersch,et al.  NMO-IgG and Devic's neuromyelitis optica: a French experience , 2008, Multiple sclerosis.

[16]  C. Lucchinetti,et al.  Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica , 2007, Neurology.

[17]  B. Weinshenker,et al.  The spectrum of neuromyelitis optica , 2007, The Lancet Neurology.

[18]  G. Hu,et al.  Alterations of striatal neurotransmitter release in aquaporin-4 deficient mice: An in vivo microdialysis study , 2007, Neuroscience Letters.

[19]  A. Pérez-Samartín,et al.  Excitotoxic damage to white matter , 2007, Journal of anatomy.

[20]  Y. Itoyama,et al.  Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. , 2007, Brain : a journal of neurology.

[21]  A. Bassols,et al.  Mapping of aggrecan, hyaluronic acid, heparan sulphate proteoglycans and aquaporin 4 in the central nervous system of the mouse , 2007, Journal of Chemical Neuroanatomy.

[22]  J. Parisi,et al.  Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. , 2007, Brain : a journal of neurology.

[23]  G. Hu,et al.  Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes , 2007, Molecular and Cellular Neuroscience.

[24]  L. Denoroy,et al.  Glutamatergic alterations in the cortex of genetic absence epilepsy rats , 2007, BMC Neuroscience.

[25]  A S Verkman,et al.  Three distinct roles of aquaporin-4 in brain function revealed by knockout mice. , 2006, Biochimica et biophysica acta.

[26]  B. Cree,et al.  Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays , 2006, Neurology.

[27]  C. Matute Oligodendrocyte NMDA receptors: a novel therapeutic target. , 2006, Trends in molecular medicine.

[28]  A. Pérez-Samartín,et al.  Activation of Kainate Receptors Sensitizes Oligodendrocytes to Complement Attack , 2006, The Journal of Neuroscience.

[29]  D. Attwell,et al.  NMDA receptors are expressed in oligodendrocytes and activated in ischaemia , 2005, Nature.

[30]  M. Salter,et al.  NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury , 2005, Nature.

[31]  A. Pérez-Samartín,et al.  Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition , 2005, Glia.

[32]  A. Verkman,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .

[33]  A. Verkman More than just water channels: unexpected cellular roles of aquaporins , 2005, Journal of Cell Science.

[34]  E. Nagelhus,et al.  Aquaporin-4 in the central nervous system: Cellular and subcellular distribution and coexpression with KIR4.1 , 2004, Neuroscience.

[35]  O. P. Ottersen,et al.  Anchoring of aquaporin-4 in brain: Molecular mechanisms and implications for the physiology and pathophysiology of water transport , 2004, Neuroscience.

[36]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[37]  A. Butt,et al.  Functions of optic nerve glia: axoglial signalling in physiology and pathology , 2004, Eye.

[38]  G. Manley,et al.  Aquaporin‐4 facilitates reabsorption of excess fluid in vasogenic brain edema , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  Geoffrey T Manley,et al.  Increased seizure threshold in mice lacking aquaporin-4 water channels , 2004, Neuroreport.

[40]  Ole Petter Ottersen,et al.  An α-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Hans Lassmann,et al.  A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. , 2002, Brain : a journal of neurology.

[42]  A. Verier,et al.  Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile , 2002, Journal of the Neurological Sciences.

[43]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[44]  G. Burbaeva,et al.  Glutamine Synthetase and Glutamine Synthetase‐Like Protein from Human Brain , 2000, Journal of neurochemistry.

[45]  J. Honnorat,et al.  Differential Expression of Collapsin Response Mediator Proteins (CRMP/ULIP) in Subsets of Oligodendrocytes in the Postnatal Rodent Brain , 2000, Molecular and Cellular Neuroscience.

[46]  M. Vergnes,et al.  Specific alteration in the expression of glial fibrillary acidic protein, glutamate dehydrogenase, and glutamine synthetase in rats with genetic absence epilepsy , 2000 .

[47]  R. Szymocha,et al.  Human T-Cell Lymphotropic Virus Type 1-Infected T Lymphocytes Impair Catabolism and Uptake of Glutamate by Astrocytes via Tax-1 and Tumor Necrosis Factor Alpha , 2000, Journal of Virology.

[48]  M. Vergnes,et al.  Specific alteration in the expression of glial fibrillary acidic protein, glutamate dehydrogenase, and glutamine synthetase in rats with genetic absence epilepsy. , 2000, Glia.

[49]  P C O'Brien,et al.  The clinical course of neuromyelitis optica (Devic’s syndrome) , 1999, Neurology.

[50]  H. Akaoka,et al.  Changes in astrocytic glutamate catabolism enzymes following neuronal degeneration or viral infection , 1997, Glia.

[51]  R. Miledi,et al.  Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[52]  T. Olsson,et al.  Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis , 1996, Journal of the Neurological Sciences.

[53]  R S Howard,et al.  Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[54]  A. Butt,et al.  Glial cells in transected optic nerves of immature rats. II. An immunohistochemical study , 1996, Journal of neurocytology.

[55]  Fang Liu,et al.  Glutamate-mediated astrocyte–neuron signalling , 1994, Nature.

[56]  J. Storm-Mathisen,et al.  An [Na+ + K+]coupledl-glutamate transporter purified from rat brain is located in glial cell processes , 1992, Neuroscience.

[57]  M. Frotscher,et al.  Astroglial processes around identified glutamatergic synapses contain glutamine synthetase: evidence for transmitter degradation , 1991, Brain Research.

[58]  P. Isaacson,et al.  Immunoproliferative small-intestinal disease. An immunohistochemical study. , 1989, The American journal of surgical pathology.

[59]  J. Winn,et al.  Brain , 1878, The Lancet.